ESR1 and breast neoplasm: When compared with non-PV carriers, breast tumors from BRCA1 PV carriers expressed significantly lower ER (15.2% vs 78.2%, p < 0.001) and lower PR (6.8% vs 41.1%, p < 0.001) staining.